Close
Help
Home Journals Subjects About My LA Reviewers Authors News Submit
.
(close)

(Ctrl-click to select multiple journals)


How should we address you?

Your email address


Enter the three character code
Visual CAPTCHA
Privacy Statement

Cancer

Get Updates

Cancer research articles, Cancer research article, Cancer journals, Cancer journal, Cancer articles, Research on Breast cancer, Cancer


Category homepages

Sign up for free journal updates
How should we address you?
Your email address
Enter the three character code
Visual CAPTCHA

peer reviewed open access journals 80




Latest news
  • Author interview with Dr Shailesh Gupta
  • - 21/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr William CS Cho
  • - 18/Jun/2010
  • Interview with Biomarkers in Cancer editorial board member Dr Xiaofeng Zhou
  • - 18/Jun/2010
  • Interview with Microbiology Insights editorial board member Dr Viroj Wiwanitkit
  • - 18/Jun/2010
  • Interview with Cell & Tissue Transplantation & Therapy editorial board member Dr Terje Forslund
  • - 17/Jun/2010
  • Interview with Nutrition and Metabolic Insights editorial board member Prof.Abdulaziz I.AL-Othaimeen
  • - 17/Jun/2010
  • Interview with Biomarker Insights editorial board member Dr Steven R. Myers
  • - 16/Jun/2010
  • Interview with Immunology and Immunogenetics Insights editorial board member Dr Robert Yarchoan
  • - 16/Jun/2010
  • Interview with International Journal of Tryptophan Research editorial board member Dr Martin Reuter
  • - 15/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Philip Crooke
  • - 15/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lalita Bharadwaj
  • - 15/Jun/2010
  • Interview with Integrative Medicine Insights editorial board member Dr Merrijoy Kelner
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Reproductive Health editorial board member Dr Lior Lowenstein
  • - 15/Jun/2010
  • Interview with Clinical Medicine Insights: Trauma and Intensive Medicine editorial board member Dr Michael Y. Wang
  • - 09/Jun/2010
  • Interview with Environmental Health Insights editorial board member Dr Lars Carlsen
  • - 09/Jun/2010
  • Interview with Evolutionary Bioinformatics editorial board member Dr Carsten Wiuf
  • - 04/Jun/2010
  • Interview with Translational Oncongenomics Editor in Chief Dr Michael Spinella
  • - 04/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Jimmy T. Efird
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Hardy Kornfeld
  • - 04/Jun/2010
  • Interview with Journal of Cell Death editorial board member Dr Bruce S. Bochner
  • - 03/Jun/2010
  • Interview with Cancer Informatics editorial board member Dr Bradley J Erickson
  • - 03/Jun/2010
  • Biomarker Insights Editor in Chief co-author of Nature cover story
  • - 06/May/2010
  • Author interview with Dr Esther Uña Cidón
  • - 26/Apr/2010
  • Author interview with Dr Thomas Ostermann
  • - 24/Mar/2010

Latest pictures




Latest articles

Most read articles


(previous 30 days)Site updates
42
Articles published:
0
Comments:
23
Blog entries:

Journal: Cancer Informatics

Editor in Chief: James Willey   |   Table of contents   |   391292 views
Get Updates
Get Updates
Get Updates
Get Updates

Journal: Cancer Growth and Metastasis

Editor in Chief: Marc D Basson   |   Table of contents   |   26776 views
Get Updates
Get Updates

Journal: Biomarkers in Cancer

Editor in Chief: Dr Barbara Guinn   |   Table of contents   |   15850 views
Get Updates
Get Updates
Abstract
Full-text PDF

IDO-Mediated Tryptophan Degradation in the Pathogenesis of Malignant Tumor Disease     (10/Jun/2010)


Immune escape is a fundamental trait of cancer in which the Th1-type cytokine interferon-γ (IFN-γ) seems to play a key role. Among other tumoricidal biochemical pathways, IFN-γ induces the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) in a variety of cells including macrophages, dendritic cells (DCs) and tumor cells. IDO activity has...


Abstract
Full-text PDF

Apolipoprotein E Allelic Frequency Altered in Women with Early-onset Breast Cancer     (24/May/2010)


Among women, the most prevalent type of cancer is breast cancer, affecting 1 out of every 8 women in the United States; in Puerto Rico, 70 out of every 100,000 will develop some type of breast cancer. Therefore, a better understand of the potential risk factors for breast cancer...


Article: The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines
Full-text PDFAbstract

The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines     (20/May/2010)


The molecular classification for breast carcinomas has been used in clinical studies with a simple surrogate panel of immunohistochemistry (IHC) markers. The objective of this current project was to study the molecular classification of commonly used breast cancer cell lines by IHC analysis. Seventeen breast cancer cell lines were harvested, fixed in formalin and made into cell blocks. IHC analyses were performed on each cell block with antibodies to estrogen receptor (ER), progesterone receptor (PR),...


Abstract
Full-text PDF

Catumaxomab in the Treatment of Malignant Ascites: the Evidence of its Therapeutic Value     (19/May/2010)


The trifunctional, bispecific antibody catumaxomab (anti-EpCAM x anti-CD3) is a new therapeutic strategy for epithelial cancer patients with symptomatic malignant ascites. The trifunctionality has the advantage of binding tumor cells and simultaneously two different immune effector cells (e.g. macrophages and T-lymphocytes). The unique binding specifities of catumaxomab induce an effective...


Abstract
Full-text PDF

An Efficient Gatekeeper Algorithm for Detecting GxE     (12/May/2010)


The risk for many complex diseases is believed to be a result of the interactive effects of genetic and environmental factors. Developing efficient techniques to identify gene-environment interactions (GxE) is important for unraveling the etiologic basis of many modern day diseases including cancer. The problem of false positives and false...


Abstract
Full-text PDF

Does Race Affect Outcomes in Triple Negative Breast Cancer?     (07/May/2010)


Background: There is discordance among studies assessing the impact of race on outcome of patients with Triple Negative Breast Cancer (TNBC). We assessed survival outcomes for African American (AA) versus Caucasian (CA) women with TNBC treated at an urban cancer center in Memphis, TN with a predominant AA patient...


Abstract
Full-text PDF

Development and Validation of Predictive Indices for a Continuous Outcome Using Gene Expression Profiles     (07/May/2010)


There have been relatively few publications using linear regression models to predict a continuous response based on microarray expression profiles. Standard linear regression methods are problematic when the number of predictor variables exceeds the number of cases. We have evaluated three linear regression algorithms that can be used for the...


Abstract
Full-text PDF

A Penalized Mixture Model Approach in Genotype/Phenotype Association Analysis for Quantitative Phenotypes     (27/Apr/2010)


A mixture normal model has been developed to partition genotypes in predicting quantitative phenotypes. Its estimation and inference are performed through an EM algorithm. This approach can conduct simultaneous genotype clustering and hypothesis testing. It is a valuable method for predicting the distribution of quantitative phenotypes among multi-locus genotypes across...


Abstract
Full-text PDF

Genes with Relevance for Early to Late Progression of Colon Carcinoma Based on Combined Genomic and Transcriptomic Information from the Same Patients     (23/Apr/2010)


Background: Genetic and epigenetic alterations in colorectal cancer are numerous. However, it is difficult to judge whether such changes are primary or secondary to the appearance and progression of tumors. Therefore, the aim of the present study was to identify altered DNA regions with significant covariation to transcription alterations...


Article: ALK-Positive Large B Cell Lymphoma—Unusual Subtype of Diffuse Large B Cell Lymphoma (DLBCL)
Full-text PDFAbstract

ALK-Positive Large B Cell Lymphoma—Unusual Subtype of Diffuse Large B Cell Lymphoma (DLBCL)     (20/Apr/2010)


Anaplastic lymphoma kinase positive diffuse large B-cell lymphoma (ALK-DLBCL) is a rare lymphoma and has been included as a separate entity in the latest WHO classification (2008) of Non-Hodgkin’s lymphomas. We report a case of 65-year-old male patient who presented with multiple subcutaneous nodules on abdominal wall. Histomorphology and Immunohistochemical profile was consistent with that of ALK-positive diffuse large B cell Lymphoma. Anaplastic lymphoma kinase (ALK) staining was cytoplasmic granular staining pattern highly indicative of...


Abstract
Pay-per-view

Current and Emerging Pharmacotherapies of Breakthrough Pain in Cancer     (19/Apr/2010)


Breakthrough pain (BTP), defined as “transitory episodes of sudden severe pain that occur on a background of otherwise controlled pain” is common and disturbing for cancer patients. Optimal management of sudden, severe, and transitory episodes of BTP requires analgesics with rapid onset and short duration of effect, ideally in convenient...


Abstract
Full-text PDF

Estimation of Hazard Functions in the Log-Linear Age-Period-Cohort Model: Application to Lung Cancer Risk Associated with Geographical Area     (14/Apr/2010)


An efficient computing procedure for estimating the age-specific hazard functions by the log-linear age-period-cohort (LLAPC) model is proposed. This procedure accounts for the influence of time period and birth cohort effects on the distribution of age-specific cancer incidence rates and estimates the hazard function for populations with different exposures to...


Abstract
Full-text PDF

EGFR and hTERT Expression as a Diagnostic Approach for Non-small Cell Lung Cancer in High Risk Groups     (08/Apr/2010)


Objective: The early detection of NSCLC is of importance because it provides chances for better outcomes. The aim of the study was to explore the clinical utility of EGFR and hTERT mRNA expression as markers for diagnosis of NSCLC. Methods: EGFR and hTERT mRNA were quantified by quantative reverse transcription...


Article: Detection of Provasopressin in Invasive and Non-invasive (DCIS) Human Breast Cancer Using a Monoclonal Antibody Directed Against the C-terminus (MAG1)
Full-text PDFAbstract

Detection of Provasopressin in Invasive and Non-invasive (DCIS) Human Breast Cancer Using a Monoclonal Antibody Directed Against the C-terminus (MAG1)     (08/Apr/2010)


The provasopressin protein (proAVP) is expressed by invasive breast cancer and non-invasive breast cancer, or ductal carcinoma in situ (DCIS). Here we demonstrate the ability of the monoclonal antibody MAG1 directed against the C-terminal end of proAVP to identify proAVP in all cases examined of human invasive cancer and DCIS (35 and 26, respectively). Tissues were chosen to represent a relevant variation in tumor type, grade, patient age, and menopausal status. By comparison, there was...


Abstract
Full-text PDF

Lipases and Related Molecules in Cancer     (07/Apr/2010)


Lipases are enzymes that catalyze the hydrolysis of lipids. Based on protein structures and sequences, lipases can be classified into different protein families. The majority of conventional mammalian lipases are members of the protein super-families of serine esterases and alpha-beta hydrolases. Differential expression of lipases and related alpha-beta hydrolases in...


Abstract
Full-text PDF

Acute Appendicitis in Neutropenic Patients with Acute Leukemia     (07/Apr/2010)


Background: In neutropenic patients with acute leukemia, acute abdomen which is usually attributed to typhlitis may be encountered. However, the diagnosis of acute appendicitis is rarely described or confirmed. Methods and Materials: A retrospective study of acute appendicitis in adult patients with acute leukemia was conducted at the Riyadh Armed...


Abstract
Full-text PDF

Fas and Cancer     (07/Apr/2010)


Apoptosis is an active process of programmed cell death. Fas is a cell-surface protein which is expressed on activated lymphocytes and known as CD95, TNFRSF6 or APO-1. Fas-L is ligand of Fas and known as CD95 LG or TNFSF6. Apoptosis or cell death is a result of binding of Fas-L...


Abstract
Full-text PDF

Inference of Cancer-specific Gene Regulatory Networks Using Soft Computing Rules     (31/Mar/2010)


Perturbations of gene regulatory networks are essentially responsible for oncogenesis. Therefore, inferring the gene regulatory networks is a key step to overcoming cancer. In this work, we propose a method for inferring directed gene regulatory networks based on soft computing rules, which can identify important cause-effect regulatory relations of gene...


Abstract
Full-text PDF

Pegylated Liposomal Doxorubicin in the Management  of Ovarian Cancer     (30/Mar/2010)


Despite the cytoreductive efforts, and the high responsiveness to standard carboplatin/pacllitaxel front-line treatment, ovarian cancer (OvCa) remains the most lethal gynaecological malignancy with a 5-yr overall survival of only 25%–30% in advanced stage disease. Among the pharmaceutical options available for treatment of OvCa, much attention has been dedicated to pegylated...


Abstract
Pay-per-view

Metastatic Colorectal Cancer: Focus on Panitumumab     (30/Mar/2010)


Biologic agents designed as targeted therapy are at the forefront of research in the field of colorectal cancer. Monoclonal antibodies targeting the epidermal growth factor receptor (EGFR) represent one such form of treatment, and the novel agent panitumumab is the first fully-human monoclonal antibody developed in this class. This drug...


Abstract
Full-text PDF

Protein-protein Interaction Reveals Synergistic Discrimination of Cancer Phenotype     (26/Mar/2010)


Cancer is a disease associated with the deregulation of multiple gene networks. Microarray data has permitted researchers to identify gene panel markers for diagnosis or prognosis of cancer but these are not sufficient to make specific mechanistic assertions about phenotype switches. We propose a strategy to identify putative mechanisms of...


Abstract
Full-text PDF

Targeting the Ubiquitin-proteasome System for the Treatment of Multiple Myeloma and Other Human Diseases     (26/Mar/2010)


The ubiquitin-proteasome-degradation system plays a key role in multiple cellular functions. Its deregulation is associated with the initiation and progression of human diseases including not only solid and hematologic malignancies but also neurologic and autoimmune disorders. This article discusses several novel mechanistic aspects of the ubiquitin-proteasome system. Moreover, it focuses...


Abstract
Full-text PDF

Pharmacotherapy Update: Vinorelbine in the Treatment  of Non-small-cell Lung Cancer     (26/Mar/2010)


Non-small cell lung cancer (NSCLC) is the most deadly cancer in the world. Vinorelbine is an active vinca-alkaloid with a broad spectrum of anti-tumour activity. In particular, it has high activity in NSCLC, where a synergy with cisplatin has been demonstrated. Recently, oral vinorelbine has shown a similar activity and...


Abstract
Full-text PDF

Prostate Cancer: Value of Transrectal Computed Ultrasound Tomography (TRCUT) in Targeted Biopsy Guidance when the Repeat or Random Biopsies Indicated: Early Experience     (23/Mar/2010)


Purpose: To evaluate the feasibility of transrectal computed ultrasound tomography (TRCUT) in localization and targeted biopsy for men who have been shown to be negative in the first biopsy guided by two-dimensional transrectal ultrasound (2D TRUS) but continue to have figures suggestive of prostate cancer, so as to minimize with...


Abstract
Full-text PDF

Characterization of the Effectiveness of Reporting Lists of Small Feature Sets Relative to the Accuracy of the Prior Biological Knowledge     (18/Mar/2010)


When confronted with a small sample, feature-selection algorithms often fail to find good feature sets, a problem exacerbated for high-dimensional data and large feature sets. The problem is compounded by the fact that, if one obtains a feature set with a low error estimate, the estimate is unreliable because training-data-based...


Abstract
Full-text PDF

Characterization of the Effectiveness of Reporting Lists of Small Feature Sets Relative to the Accuracy of the Prior Biological Knowledge     (18/Mar/2010)


When confronted with a small sample, feature-selection algorithms often fail to find good feature sets, a problem exacerbated for high-dimensional data and large feature sets. The problem is compounded by the fact that, if one obtains a feature set with a low error estimate, the estimate is unreliable because training-data-based...


Abstract
Full-text PDF

Identification of Gene Networks Associated with Acute Myeloid Leukemia by Comparative Molecular Methylation and Expression Profiling     (17/Mar/2010)


Around 80% of acute myeloid leukemia (AML) patients achieve a complete remission, however many will relapse and ultimately die of their disease. The association between karyotype and prognosis has been studied extensively and identified patient cohorts as having favourable [e.g. t(8; 21), inv (16)/t(16; 16), t(15; 17)], intermediate [e.g. cytogenetically...


Article: A Novel Strategy for Mechanism Based Computational Drug Discovery
Full-text PDFAbstract

A Novel Strategy for Mechanism Based Computational Drug Discovery     (10/Mar/2010)


Glioma, the common brain tumor, which arises from the glial cells, offers worse prognosis and therapy than any other tumors. Despite the genetic and pathological diversities of malignant gliomas, common signaling pathways that drive cellular proliferation, survival, invasion and angiogenesis have been identified. Very often, various tyrosine kinase receptors are inappropriately activated in human brain tumors and contribute to tumor malignancy. During such tumourous states where multiple pathways are involved, a few of them are...


Abstract
Full-text PDF

Comparison of Two Output-Coding Strategies for Multi-Class Tumor Classification Using Gene Expression Data and Latent Variable Model as Binary Classifier     (10/Mar/2010)


Multi-class cancer classification based on microarray data is described. A generalized output-coding scheme based on One Versus One (OVO) combined with Latent Variable Model (LVM) is used. Results from the proposed One Versus One (OVO) output- coding strategy is compared with the results obtained from the generalized One Versus All...


Abstract
Full-text PDF

Inhibition of MLK3 Decreases Proliferation and Increases Antiproliferative Activity of Epidermal Growth Factor Receptor (EGFR) Inhibitor in Pancreatic Cancer Cell Lines     (09/Mar/2010)


Pancreatic adenocarcinoma is associated with advanced presentation and poor survival. Currently approved therapies have minimal effect on patient survival. Pancreatic adenocarcinomas have a high incidence of activated K-RAS, which may confer resistance to epidermal growth factor receptor (EGFR) inhibitors. Mixed lineage kinase-3 (MLK3) is a MAP3K that activates multiple MAPK...